Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: A case report

Journal of Korean Medical Science

Volumn 23, Issue 4, 2008, Pages 740-743

  Cho, Jaeho ^a   Gwi, Eon Kim ^a   Koon, Ho Rha ^b   Joong, Bae Ahn ^b   Chang, Geol Lee ^a   Suh, Chang Ok ^a   Seong, Jinsil ^a   Ki, Chang Keum ^a   Song, Ie Kim ^a   Lee, Yoon Hee ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Carcinoma, renal cell; Intensity modulated; Radioresistance; Radiotherapy

Indexed keywords

ARTICLE; CASE REPORT; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY CARCINOMA; KIDNEY TUMOR; MIDDLE AGED; PATHOLOGY; RADIATION DOSE FRACTIONATION; TUMOR RECURRENCE;

CARCINOMA, RENAL CELL; DOSE FRACTIONATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 50449107631     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2008.23.4.740     Document Type: Article

References (10)

1. DiBiase SJ, Valicenti RK, Schultz D, Xie Y, Gomella LG, Corn BW. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol 1997; 158: 746-9.
2. Wronski M, Maor MH, Davis BJ, Sawaya R, Levin VA. External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 1997; 37: 753-9.
3. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985; 11: 1699-707.
4. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 2003; 98: 342-9.
5. Gogus C, Baltaci S, Beduk Y, Sahinli S, Kupeli S, Gogus O. Isolated local recurrence of renal cell carcinoma after radical nephrectomy: experience with 10 cases. Urology 2003; 61: 926-9.
6. Itano NB, Blute ML, Spotts B, Zincke H. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000; 164: 322-5.
7. Schrodter S, Hakenberg OW, Manseck A, Leike S, Wirth MP. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma. J Urol 2002; 167: 1630-3.
8. Master VA, Gottschalk AR, Kane C, Carroll PR. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol 2005; 174: 473-7.
9. Tanguay S, Pisters LL, Lawrence DD, Dinney CP. Therapy of locally recurrent renal cell carcinoma after nephrectomy. J Urol 1996; 155: 26-9.
10. Figlin RA, Abi-Aad AS, Belldegrun A, deKernion JB. The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma. Semin Oncol 1991; 18 (5 Suppl 7): 102-7.